Truist Securities increased its price target for Exelixis (NASDAQ:EXEL) shares to $43.00, up from the previous target of $42.00, while reaffirming a Buy rating on the stock. The new target represents ...
Even Target has turned on the Human Rights Campaign, withdrawing from the Corporate Equality Index after Trump's DEI orders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback